Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cardlytics Q3 Adj. EPS $(0.07) Beats $(0.15) Estimate, Sales $52.031M Miss $54.263M Estimate

Author: Benzinga Newsdesk | November 05, 2025 04:26pm
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 53.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $52.031 million which missed the analyst consensus estimate of $54.263 million by 4.11 percent. This is a 22.41 percent decrease over sales of $67.057 million the same period last year.

Posted In: CDLX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist